These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21384867)

  • 1. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
    Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
    J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
    Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
    Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
    van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
    Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and activity in the relaxin family of peptides.
    Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
    Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.
    van der Westhuizen ET; Wade JD; Sexton PM; Summers RJ
    Ann N Y Acad Sci; 2009 Apr; 1160():105-7. PubMed ID: 19416168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3.
    Haugaard-Kedström LM; Lee HS; Jones MV; Song A; Rathod V; Hossain MA; Bathgate RAD; Rosengren KJ
    J Biol Chem; 2018 Oct; 293(41):15765-15776. PubMed ID: 30131342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
    Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
    Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural properties of relaxin chimeras.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
    Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
    Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
    Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
    Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
    Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
    Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
    J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
    Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
    Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
    Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
    J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
    Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
    Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
    Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
    J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.